Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.
Nanki
T
T
Koike
R
R
Miyasaka
N
N
D000208:Acute Disease; D000410:Alanine Transaminase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D017809:Fatal Outcome; D005234:Fatty Liver / Q000139:chemically induced*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced; D017093:Liver Failure / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase